Reported
Lowest–highest estimate
The chart could not be loaded. Try again or view the figures below.
| Value | YoY | Lowest–highest | Analysts | |
|---|---|---|---|---|
J
Jiangsu Sinopep Allsino Biopharmaceutical Co Ltd
SSE:688076
Jiangsu Sinopep Allsino Biopharmaceutical Co Ltd
SSE:688076
Price:
28.93
CNY
-2.79%
Market Closed
Market Cap:
¥9.2B
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
J
|
Jiangsu Sinopep Allsino Biopharmaceutical Co Ltd
SSE:688076
|
CN |
|
Service Corporation International
NYSE:SCI
|
US |
|
Japan Post Bank Co Ltd
TSE:7182
|
JP |
Why do you have more estimates than other sites?
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is Jiangsu Sinopep Allsino Biopharmaceutical Co Ltd's stock price target?
Not Available
Jiangsu Sinopep Allsino Biopharmaceutical Co Ltd does not have any price targets made by Wall Street professionals.
What is the Revenue forecast for Jiangsu Sinopep Allsino Biopharmaceutical Co Ltd?
Projected CAGR
43%
43%
The compound annual growth rate for Revenue over the next 2 years is 43%.
What is the Gross Profit forecast for Jiangsu Sinopep Allsino Biopharmaceutical Co Ltd?
Projected CAGR
37%
37%
The compound annual growth rate for Gross Profit over the next -1 years is 37%.
What is the Operating Income forecast for Jiangsu Sinopep Allsino Biopharmaceutical Co Ltd?
Projected CAGR
42%
42%
The compound annual growth rate for Operating Income over the next 1 year is 42%.
What is the Pre-Tax Income forecast for Jiangsu Sinopep Allsino Biopharmaceutical Co Ltd?
Projected CAGR
-25%
-25%
The compound annual growth rate for Pre-Tax Income over the next -1 years is -25%.
What is the Net Income forecast for Jiangsu Sinopep Allsino Biopharmaceutical Co Ltd?
Projected CAGR
-26%
-26%
The compound annual growth rate for Net Income over the next -1 years is -26%.